Home・Lista de Ações・Anika Therapeutics Inc

Anika Therapeutics Inc

Fechado

SetorSaúde

21.15 2.57

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

20.39

Máximo

21.31

Indicadores-chave
By Trading Economics
Rendimento	8.4M 3.3M
Vendas	3M 33M
EPS	0.3
Margem de lucro	10.147
Funcionários	235
EBITDA	8.3M 4.9M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+0.67% upside

Dividendos
By Acuity
Próximos Ganhos	4 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	80M 278M
Abertura anterior	18.58
Fecho anterior	21.15

Sentimento de Notícias

By Acuity

50%

112 / 339 Ranking em Healthcare

Anika Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de set. de 2026, 19:16 UTC

Anika Therapeutics shares are advancing despite broader market volatility and renewed inflation concerns. No specific news was identified to explain today's price movement.

11 de set. de 2026, 22:41 UTC

Anika Therapeutics Inc shares are lower in after-market hours, declining from earlier returns. The stock remains below its 20-day moving average and near recent lows.

10 de set. de 2026, 20:07 UTC

Anika Therapeutics Inc. is higher today, with no specific news identified. The broader market remains flat amid recent interest rate hikes from the European Central Bank.

9 de set. de 2026, 20:07 UTC

Anika Therapeutics Inc's shares are lower today, with no specific news identified. The stock remains below its 20-day moving average.

8 de set. de 2026, 20:07 UTC

Anika Therapeutics shares are higher amid a broader market recovery, despite no specific company news driving the price movement.

3 de set. de 2026, 20:07 UTC

Anika Therapeutics Inc shares declined during Thursday's session, reflecting ongoing selling pressure amid broader market dynamics and rising jobless claims.

2 de set. de 2026, 20:08 UTC

Anika Therapeutics Inc shares are higher today, reflecting positive momentum despite no specific company news. The stock remains above its 20-day moving average.

1 de set. de 2026, 19:11 UTC

Anika Therapeutics Inc is gaining today, despite earlier session pullbacks. Broader market movements reflect rising bond yields amid expectations for monetary tightening.

31 de ago. de 2026, 22:16 UTC

Anika Therapeutics Inc shares are lower in after-market trading amid broader market concerns over inflation and potential interest rate hikes. No specific company news was identified.

28 de ago. de 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, trading above the 20-day moving average and near the upper end of their one-month range.

27 de ago. de 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market hours with no specific news identified for the decline. The stock has gained significantly over the past month.

26 de ago. de 2026, 21:51 UTC

Anika Therapeutics Inc shares are higher in after-market trading, continuing positive momentum after three consecutive sessions of gains, despite no specific company news.

25 de ago. de 2026, 21:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading, with no specific news identified for the decline. The stock remains above its 20-day moving average.

24 de ago. de 2026, 19:56 UTC

Anika Therapeutics Inc. shares are lower today amid broader market pressures, despite strong performance over the past month and trading above its 20-day moving average.

21 de ago. de 2026, 21:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, showing unusual strength. No specific news was identified to explain this price movement.

20 de ago. de 2026, 21:01 UTC

Anika Therapeutics shares are trading higher in after-market hours, showing steady gains since Thursday's close and remaining above the 20-day moving average.

19 de ago. de 2026, 22:01 UTC

Anika Therapeutics Inc shares are lower in after-market trading. No specific news was identified to explain the decline following Wednesday's close.

18 de ago. de 2026, 20:06 UTC

Anika Therapeutics Inc's shares are higher during Tuesday's session, reflecting overall positive market performance, despite pulling back slightly from an earlier peak.

17 de ago. de 2026, 20:06 UTC

Anika Therapeutics Inc shares are lower amid broader market declines, reflecting significant downward pressure following disappointing U.S. retail sales data for July.

14 de ago. de 2026, 22:01 UTC

Anika Therapeutics Inc is trading higher in after-market hours, reflecting stability near the upper end of its one-month range and above its 20-day moving average.

13 de ago. de 2026, 20:01 UTC

Anika Therapeutics Inc shares declined during Thursday's session, continuing a downward trend since Wednesday's close. No specific news was identified to explain the movement.

12 de ago. de 2026, 19:51 UTC

Anika Therapeutics Inc is higher today, supported by positive sentiment from a recent inflation report, despite no specific company news identified.

11 de ago. de 2026, 20:02 UTC

Anika Therapeutics Inc is trading higher, showing notable gains and peaking after an early dip, with no specific news identified to explain the movement.

10 de ago. de 2026, 20:01 UTC

Anika Therapeutics shares declined during Monday's session, hitting a low of -3.68%, amid cautious investor sentiment following recent labor market data.

7 de ago. de 2026, 20:03 UTC

Anika Therapeutics Inc shares are higher today, continuing a strong upward trend since Thursday's close amid broader market gains. No specific news was identified.

6 de ago. de 2026, 20:02 UTC

Anika Therapeutics Inc. is trading higher Thursday, reflecting strong momentum despite a pullback from session highs. Broader economic data may influence investor sentiment.

5 de ago. de 2026, 21:01 UTC

Anika Therapeutics Inc shares are higher in after-market hours, maintaining a gain above the 20-day moving average and near the upper end of the one-month range.

4 de ago. de 2026, 19:51 UTC

Anika Therapeutics Inc. shares are lower today amid unusual volatility, despite a broader market reaction to declining crude oil prices.

3 de ago. de 2026, 19:51 UTC

Anika Therapeutics Inc is sharply higher today, with no specific company news identified. Broader market dynamics, including falling oil prices, may be influencing performance.

31 de jul. de 2026, 23:06 UTC

Anika Therapeutics Inc shares are higher in after-market trading, reflecting notable volatility earlier in the session and strong recent performance above the 20-day moving average.

Comparação entre Pares

Variação de preço

Anika Therapeutics Inc Previsão

Preço-alvo

By TipRanks

0.67% parte superior

Previsão para 12 meses

Média 21 USD 0.67%

Máximo 21 USD

Mínimo 21 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Anika Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

Comprar

Manter

Vender

Com base em 2 analistas que deram avaliações de ações para Anika Therapeutics Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

112 / 339 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.